Immunotherapy honing in on multiple targets shows promise in pancreatic cancer
This novel immunotherapy may help the immune system recognize and attack cancer cells in a way that other immunotherapies have not been able to do thus far.
Read More
This novel immunotherapy may help the immune system recognize and attack cancer cells in a way that other immunotherapies have not been able to do thus far.
Read MoreAn 18-year survivor of neuroblastoma is believed to represent the longest reported remission to date in a patient treated with chimeric antigen receptor (CAR) T cell therapy.
Read MoreResearchers relate their journey to finding a promising method to address CAR T cell challenges in treating solid tumors.
Read MoreThe CPRIT awards support developmental research focusing on promising new insights into cancer treatment and innovative core facilities.
Read MoreThis study shows that this therapy can effectively get to the tumor, and the addition of C7R safely augments antitumor activity.
Read MoreCAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read MoreFrom the Labs celebrates Baylor Women in Science! Here is the second one in the series. (See the other Women in Science posts here)
Read MoreSince he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to
Read MoreT cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read MoreA bone marrow transplant can be a life-saving treatment for patients with certain cancers and other serious illnesses that have not responded to conventional chemotherapies.
Read More